Nektar Therapeutics (NASDAQ:NKTR)

BATS BZX Real-Time Price
 +0.31 / +2.13%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. These technology platforms are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. Nektar Therapeutics was founded in 1990 and is headquartered in San Francisco, CA.

Contact Information

Nektar Therapeutics
455 Mission Bay Boulevard South
San Francisco California 94158
P:(415) 482-5300
Investor Relations:
(415) 482-5585



Mutual fund holders72.16%
Other institutional20.08%
Individual stakeholders1.86%

Top Executives

Howard W. RobinPresident, Chief Executive Officer & Director
John NicholsonChief Financial Officer & Senior Vice President
Stephen K. DobersteinChief Scientific Officer & Senior Vice President
Ivan P. GergelChief Medical Officer & SVP-Drug Development
Gilbert M. LabrucherieSecretary, Senior Vice President & General Counsel

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.